UZ Leuven
Leuven, 3000, Belgium
Location status: Recruiting
Location contact
Colette Barlé
CONTACT
++32 16 341699
Marc Miserez, Prof.Dr.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04622410
Registry for Hirschsprung disease of the BELAPS (Belgian Association of Pediatric Surgery) Protocol Short Title/Acronym
/ Sponsor name BELAPS Principal Investigator Prof. Dr. Marc Miserez Medical condition or disease under investigation Hirschsprung's disease Purpose of clinical study To register pre-, intra- and postoperative data in order to improve surgical care to paediatric patients with Hirschsprung's disease in Belgium. Primary objective The primary objective is to evaluate defecation habits at 3.5-5.5 years after surgery. Secondary objective (s) Evaluating the long-term results and evaluate risk factors for constipation / incontinence. Study Design Prospective registry Endpoints Krickenbeck score, urinary, sexual and QoL evaluation
Interested in participating?
Request InfoUp to 18 year
All sexes
Observational
Leuven, 3000, Belgium
Location status: Recruiting
Colette Barlé
CONTACT
++32 16 341699
Marc Miserez, Prof.Dr.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Hirschsprung Disease, surgery
Exclusion criteria
-
Time frame: at least 10 years postoperatively
Contact information is provided by the study sponsor or research team.
Universitaire Ziekenhuizen KU Leuven
Other
Registry for Hirschsprung Disease of the BELAPS (Belgian Association of Pediatric Surgery)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00478712
Colonic Diseases, Congenital Abnormalities
New York, United States
View Trial DetailsNCT06072976
Colonic Diseases, Congenital Abnormalities
Seattle, Washington, United States
View Trial DetailsNCT07519915
Colonic Diseases, Congenital Abnormalities
Erlangen, Germany
View Trial DetailsNCT06573723
Abnormalities, Multiple, Adrenal Gland Diseases
Buenos Aires, Argentina
View Trial Details